Body Dysmorphic Disorder (BDD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

Body Dysmorphic Disorder (BDD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape


Summary

This reports provides a data-driven overview of the current and future competitive landscape in BDD therapeutics.
  • There will be 67,698,071 total prevalent cases of BDD in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast.
  • No approved marketed drugs are currently available for the treatment of BDD.
  • R&D activity within the BDD space is negligible, with no pipeline products in late-stage clinical development.
  • Non-commercial sponsors currently dominate the BDD clinical development space.
  • No deals were implemented among companies developing BDD assets in the past 24 months.
Scope

GlobalData’s Body Dysmorphic Disorder (BDD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.

Components of the report include -
  • Disease Landscape
  • Disease Overview
  • Epidemiology Overview
  • Treatment Overview
  • Marketed Products Assessment
  • Pricing and Reimbursement Assessment
  • Pipeline Assessment
  • Late-to-mid-stage Pipeline Drugs
  • Phase Transition Success Rate and Likelihood of Approval
  • Clinical Trials Assessment
  • Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
  • Enrolment Analytics, Site Analytics, Feasibility Analysis
  • Deals Landscape
  • Mergers, Acquisitions, and Strategic Alliances by Region
  • Overview of Recent Deals
  • Commercial Assessment
  • Key Market Players
  • Future Market Catalysts
Reasons to Buy
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the BDD market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global BDD market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.


  • Report Scope
  • Key Findings
  • Disease Overview
  • Epidemiology Overview
    • Epidemiology Overview: Total Prevalent Cases of BDD in 2023 and 2028
  • Treatment Overview
    • Treatment Guidelines
    • Management of BDD
  • Marketed Drugs Assessment
    • Marketed Drugs - Leading Marketed Drugs in BDD
  • Pricing and Reimbursement Assessment
    • Marketed Drugs - Annual Therapy Cost
  • Pipeline Drugs Assessment
    • Pipeline Drugs Overview - Pipeline Drugs in BDD
    • Pipeline Drugs - Phase Transition Success Rate and Likelihood of Approval in CNS Disorders
  • Clinical Trials Assessment
    • Clinical Trials in BDD - Historical Overview
    • Clinical Trials in BDD - Overview by Phase
    • Clinical Trials in BDD - Overview by Status
    • Clinical Trials in BDD - Overview by Phase for Ongoing and Planned Trials
    • Clinical Trials in BDD - Trials with a Virtual Component
    • Clinical Trials in BDD - Overview of Trials by Geography
    • Clinical Trials in BDD - Single-Country and Multinational Trials by Region
    • Clinical Trials in BDD - Top Sponsors with Breakdown by Phase
    • Clinical Trials in BDD - Top Sponsors with Breakdown by Status
    • Clinical Trials in BDD - Overview by Endpoint Status
    • Clinical Trials in BDD - Overview by Race and Ethnicity
    • Clinical Trials in BDD - Overview of Sites by Geography
    • Clinical Trials in BDD - Top Countries for Trial Sites
    • Clinical Trials in BDD - Top Sites Globally
  • Deals Landscape
    • Deals Landscape - Mergers, Acquisitions, and Strategic Alliances in BDD by Region
  • Commercial Assessment
    • Commercial Assessment - Key Market Players in BDD
  • Future Market Catalysts
    • Future Market Catalysts - Upcoming Market Catalysts in BDD
  • Appendix
    • Methodology
    • Methodology - Phase Transition Success Rate and Likelihood of Approval Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings